EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

L-TPS05 - Drug allergy 06

Friday 13 Jun, 12:00 PM - 13:00 PM Glasgow, United Kingdom
Poster Zone Thematic Poster Session
A model based economic evaluation to assess impact of Penicillin Allergy in COPD patients
Assessing the Accuracy of Penicillin Allergy Labels in Paediatric Care: Focusing on Educational Gaps in Both Families and Healthcare Workers
Beyond the Label: A Multidisciplinary Effort to De-label Penicillin Allergy
Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management
Comparison of the Negative Predictive Values of One-Day and Five-Day Drug Provocation Tests in Late-Mild and Cutaneous Beta-Lactam Allergies in Children
Complex cohort analysis of Stevens-Johnson syndrome/toxic epidermal necrolysis cases in Moscow Healthcare network with special focus on prediction of fatal outcomes
Development of multiple drug hypersensitivity after DRESS syndrome induced by piperacillin/tazobactam
Documentation of drug allergy in the Electronic Health Record (EHR) at a Tertiary paediatric allergy service in the UK
Extensive allergological workup in the management of immediate adverse drug reactions to chemotherapy- a single centre experience
Healthcare interoperability: the promises and pitfalls relating to penicillin allergy delabelling
Hypersensitivity to Iodinated Contrast Media: Diagnostic Evaluation and Re-exposure Outcomes
Improving inpatient antimicrobial stewardship through single dose oral amoxicillin challenge among penicillin allergic veterans
Perioperative hypersensitivity reaction (POH) with tranexamic acid: study of 2 cases
Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q): A Cross-Cultural Adaptation and Reliability Study
Whole exome sequencing in drug induced angioedema by angiotensin-converting enzyme inhibitors: a pilot study in five patients

Speakers